Recombinant CTRP3 reduced glucose output in cultured rat hepatoma cells by suppressing gluconeogenic genes [10], significantly inhibited LPS-induced IL-6 and TNF-α secretion in THP-1 cells, and reduced NF-κB p65 activity [12]. The gene discussed is IL6; the disease is hepatocellular carcinoma.